首页> 外文期刊>Medical dosimetry: official journal of the American Association of Medical Dosimetrists >Volumetric-modulated arc radiotherapy for pancreatic malignancies: Dosimetric comparison with sliding-window intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy
【24h】

Volumetric-modulated arc radiotherapy for pancreatic malignancies: Dosimetric comparison with sliding-window intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy

机译:容积调制弧线放射疗法治疗胰腺恶性肿瘤:与滑动窗口强度调制放射疗法和3维保形放射疗法进行剂量学比较

获取原文
获取原文并翻译 | 示例
       

摘要

Volumetric-modulated arc radiotherapy (VMAT) is an iteration of intensity-modulated radiotherapy (IMRT), both of which deliver highly conformal dose distributions. Studies have shown the superiority of VMAT and IMRT in comparison with 3-dimensional conformal radiotherapy (3D-CRT) in planning target volume (PTV) coverage and organs-at-risk (OARs) sparing. This is the first study examining the benefits of VMAT in pancreatic cancer for doses more than 55.8. Gy. A planning study comparing 3D-CRT, IMRT, and VMAT was performed in 20 patients with pancreatic cancer. Treatments were planned for a 25-fraction delivery of 45. Gy to a large field followed by a reduced-volume 8-fraction external beam boost to 59.4. Gy in total. OARs and PTV doses, conformality index (CI) deviations from 1.0, monitor units (MUs) delivered, and isodose volumes were compared. IMRT and VMAT CI deviations from 1.0 for the large-field and the boost plans were equivalent (large field: 0.032 and 0.046, respectively; boost: 0.042 and 0.037, respectively; p > 0.05 for all comparisons). Both IMRT and VMAT CI deviations from 1.0 were statistically superior to 3D-CRT (large field: 0.217, boost: 0.177; p < 0.05 for all comparisons). VMAT showed reduction of the mean dose to the boost PTV (VMAT: 61.4. Gy, IMRT: 62.4. Gy, and 3D-CRT: 62.3. Gy; p < 0.05). The mean number of MUs per fraction was significantly lower for VMAT for both the large-field and the boost plans. VMAT delivery time was less than 3 minutes compared with 8 minutes for IMRT. Although no statistically significant dose reduction to the OARs was identified when comparing VMAT with IMRT, VMAT showed a reduction in the volumes of the 100% isodose line for the large-field plans. Dose escalation to 59.4. Gy in pancreatic cancer is dosimetrically feasible with shorter treatment times, fewer MUs delivered, and comparable CIs for VMAT when compared with IMRT.
机译:体积调制弧线放射疗法(VMAT)是强度调制放射线疗法(IMRT)的迭代,两者均提供高度共形的剂量分布。研究表明,VMAT和IMRT在计划目标体积(PTV)覆盖和高危器官(OAR)保留方面比3D适形放疗(3D-CRT)优越。这是第一项研究VMAT剂量超过55.8时在胰腺癌中的益处的研究。 Gy。在20例胰腺癌患者中进行了一项比较3D-CRT,IMRT和VMAT的计划研究。计划对25分数的45. Gy进行大范围的治疗,然后将体积减小的8分数的外部射束提高到59.4。总共Gy。比较了OARs和PTV剂量,从1.0的适形指数(CI)偏差,递送的监测单位(MUs)和等剂量。对于大视野和增强计划,IMRT和VMAT CI与1.0的偏差是等效的(大视野:分别为0.032和0.046;增强:分别为0.042和0.037;对于所有比较,p> 0.05)。从1.0开始,IMRT和VMAT CI偏差均在统计学上优于3D-CRT(大视野:0.217,增强值:0.177;对于所有比较,p <0.05)。 VMAT显示增强PTV的平均剂量减少(VMAT:61.4。Gy,IMRT:62.4。Gy,3D-CRT:62.3。Gy; p <0.05)。对于大场和助推计划,VMAT的每级平均MU数均显着降低。 VMAT的交付时间少于3分钟,而IMRT的交付时间为8分钟。尽管在比较VMAT与IMRT时未发现OAR的统计学显着剂量减少,但对于大视野计划,VMAT显示出100%等剂量线的体积减少了。剂量提升至59.4。与IMRT相比,胰腺癌的Gy在剂量学上可行,治疗时间更短,递送的MU更少,VMAT的CI相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号